Facility

Reckitt Benckiser Group announced today that it is expanding its U.S. manufacturing footprint by acquiring a 310,000 ft² pharmaceutical site in Wilson, North Carolina. The Slough, U.K.–based company said it will invest £155 million ($200 million) to establish a manufacturing facility in Wilson to produce Mucinex tablets and liquids to meet increased U.S. demand. Reckitt…

Sanofi recently announced that it is investing €40 million in its Lyon Gerland bioproduction site as it seeks to bolster its position in the immunology space. The investment will support production in France of the transplant drug Thymoglubulin, including €25 million toward developing and manufacturing a second-generation version of the drug. The remaining €15 million…

A maker of pharma manufacturing workstations says wearable biometric ID products are solving a security and efficiency challenge. Traditionally, pharmaceutical manufacturers have used a complex patchwork of access points, workstations, and tools, according to Fremont, California–based Arista Corp. Think badges, passwords and more, with the potential for someone other than the intended operator to gain…

Otsuka Holdings will pay ICU Medical (Nasdaq: ICUI) an upfront payment of $200 million as part of a joint venture to enter the U.S. IV products market, which has been facing hurricane-related shortages this fall. The partnership — which involves  ICU Medical providing commercial services for Otsuka’s Otsuka Pharmaceutical Factory (OPF) subsidiary — also includes…

MilliporeSigma, Merck KGaA’s U.S. and Canada Life Science business, announced a $76 million expansion of its ADC manufacturing capabilities and capacity. The company is expanding the capacity at its Bioconjugation Center of Excellence facility in St. Louis. This investment triples existing capacity and enhances the company’s contract development and manufacturing organization (CDMO) offering. MilliporeSigma said…

PharmaLogic announced today that it opened a new radiopharmaceutical production and research facility in Salt Lake City. The new state-of-the-art facility marks “a major step forward” in the CDMO’s mission to deliver diagnostic and therapeutic radiopharmaceuticals to patients across North America, according to a news release. PharmaLogic said it chose to establish the facility in…

Johnson & Johnson recently announced plans to invest more than $2 billion in a new manufacturing facility in North Carolina. The company plans to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina, to expand the production of its pipeline of innovative biologics. The expansion supports J&J’s broader plan to advance more than 70…

Roche recently announced it opened its latest Pharma Research and Early Development (pRED) Center in Basel Switzerland. The new facility is equipped with cutting-edge technologies and houses around 1,000 laboratory and office workspaces, according to the company. It is located at the company’s global headquarters and brings together teams of scientists and researchers to accelerate…

Eli Lilly and Co. recently announced that it’s spending $1 billion to expand its Limerick, Ireland, manufacturing site. The goal of the expansion, announced Sept. 12, is to increase the production of biologic active ingredients, including those for the company’s recently approved treatment for early symptomatic Alzheimer’s disease. The company announced in July that the…

Eugia Pharma Specialties’ manufacturing hub in India has received an FDA warning letter based on inspections of its facility. The new warning letter is tied to previous warnings about the company’s Unit III Formulation manufacturing facility. The unit makes terminally sterilized products. Eugia’s Hyderabad, India-based facility received an official action indicated (OAI) status notice in…